和胃化湿汤合厚朴三物汤治疗慢性萎缩性胃炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R573.32

基金项目:

湖州市科学技术局项目(2019GY22)


Clinical Study on Hewei Huashi Decoction Combined with Houpu Sanwu Decoction for Chronic Atrophic Gastritis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察和胃化湿汤合厚朴三物汤治疗慢性萎缩性胃炎(CAG) 的效果及对核转录因子- κB(NF-κB) /B 淋巴细胞瘤2(Bcl-2) 通路的影响。方法:选择CAG 患者120 例,按随机数字表法分为对照 组和观察组各60 例。对照组接受常规对症治疗,观察组在对照组基础上加用和胃化湿汤合厚朴三物汤口服。 2 组均治疗1 个月。评价2 组临床疗效,比较2 组治疗前后中医证候评分、血清胃蛋白酶原Ⅰ(PGⅠ)、胃蛋 白酶原Ⅱ(PGⅡ) 水平、PGⅠ/PGⅡ及胃黏膜NF-κB、Bcl-2 蛋白变化。观察不良反应发生情况。结果:观察 组总有效率为93.33%,高于对照组78.33%(P<0.05)。治疗后,2 组胃脘痞胀、恶心呕吐、口苦口臭、大便 黏滞、胃脘灼热评分较治疗前下降(P<0.05),且观察组各项评分低于对照组(P<0.05)。治疗后,2 组血 清PGⅠ水平及PGⅠ/PGⅡ较治疗前升高,PGⅡ水平较治疗前下降(P<0.05);且观察组PGⅠ水平及PGⅠ/ PGⅡ高于对照组,PGⅡ水平低于对照组(P<0.05)。治疗后,2 组NF-κB、Bcl-2 蛋白阳性表达率较治疗前下 降(P<0.05),且观察组低于对照组(P<0.05)。2 组不良反应发生率比较,差异无统计学意义(P>0.05)。 结论:和胃化湿汤合厚朴三物汤治疗CAG 效果确切,安全性良好,有助于降低胃黏膜萎缩程度,修复胃黏 膜,机制可能与抑制NF-κB/Bcl-2 信号通路激活有关。

    Abstract:

    Abstract: Objective: To observe the curative effect of the therapy of Hewei Huashi Decoction combined with Houpu Sanwu Decoction on chronic atrophic gastritis (CAG) and its effect on nuclear transcription factor- κB (NF- κB) and B- cell lymphoma 2 (Bcl- 2) pathway. Methods: A total of 120 CGA patients were selected and divided into the control group and the observation group according to the random number table method, with 60 cases in each group. The control group was given routine symptomatic treatment, and the observation group was additionally treated with oral administration of Hewei Huashi Decoction combined with Houpu Sanwu Decoction based on the treatment of the control group. Both groups were treated for 1 month. The clinical effects in the two groups were evaluated; the traditional Chinese medicine syndrome scores,levels of serum pepsinogenⅠ(PGⅠ) and pepsinogenⅡ(PGⅡ),and changes of PG Ⅰ/PG Ⅱ, NF- κB in gastric mucosa and Bcl- 2 protein were compared before and after treatment between the two groups;the incidence of adverse reactions was observed. Results:The total effective rate was 93.33% in the observation group,higher than that of 78.33% in the control group (P< 0.05). After treatment, the scores of stuffiness and distension of gastric cavity, nausea and vomiting, bitter taste and fetid breath,sloppy stool and scorching heat in the gastric cavity in the two groups were decreased when compared with those before treatment (P<0.05), and the above five scores in the observation group were lower than those in the control group (P<0.05). After treatment,the serum PGⅠ levels and PGⅠ/PGⅡ in both groups were increased when compared with those before treatment,and the serum PG II levels were decreased when compared with those before treatment (P<0.05);the serum PG Ⅰ level and PG Ⅰ/PG Ⅱ in the observation group were higher than those in the control group, and the serum PG II level was lower than that in the control group (P<0.05). After treatment, the positive expression rates of NF-κB and Bcl-2 protein in the two groups were decreased when compared with those before treatment (P<0.05),and the above two rates in the observation group were lower than those in the control group (P<0.05). There was no significant difference being found in the comparison of incidence of adverse reactions between the two groups (P>0.05). Conclusion:The therapy of Hewei Huashi Decoction combined with Houpu Sanwu Decoction has a definite curative effect on CAG with good safety,which can help decrease the atrophic degree of gastric mucosa and recover the gastric mucosa,whose mechanism may be related to the inhibition of activation of NF-κB/Bcl-2 signal pathway.

    参考文献
    相似文献
    引证文献
引用本文

费侃强,刘加新,李莉.和胃化湿汤合厚朴三物汤治疗慢性萎缩性胃炎临床研究[J].新中医,2023,55(17):107-111

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-09-07
  • 出版日期:
文章二维码